RSS-Feed abonnieren
DOI: 10.1055/s-2002-32076
Transport of Alkamides from Echinacea Species through Caco-2 Monolayers[1]
Publikationsverlauf
July 31, 2001
November 11, 2001
Publikationsdatum:
07. Juni 2002 (online)
![](https://www.thieme-connect.de/media/plantamedica/200205/lookinside/thumbnails/10.1055-s-2002-32076-1.jpg)
Abstract
To gain more insights into the human intestinal absorption of alkamides from Echinacea species, transport studies were performed with the human adenocarcinoma colonic cell line Caco-2 (ATCC) as a model to assess the epithelial transport of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (1/2). 30 minutes after apical loading of 25 μg/ml 1/2, about 15 % of these alkamides were detectable on the basolateral side. Close monitoring of the transport during 6 hours revealed a nearly complete transport to the basolateral side after 4 hours and no significant metabolism was observable. Transport experiments performed at 4 °C showed only a slight decrease in transport, which is a strong hint that dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (1/2) cross biological membranes by passive diffusion. Nearly the same results were obtained after preincubation of the Caco-2 cells with lipopolysaccharides (LPS) or phorbol 12-myristate-13-acetate (PMA) to mimic an inflammatory status. These results support the assumption that the alkamides can be easily transported from the intestinum and hence may contribute to the in vivo effects of Echinacea preparations.
1 This article is dedicated in deep gratitude to Prof. Dr. Otto Sticher (ETH Zurich, Institute of Pharmaceutical Sciences) on the occasion of his 65th birthday.
References
-
1 Bauer R. Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals. In: Wagner H., Ed
Immunomodulatory agents from plants. Birkhäuser Verlag 1999: 41-88 - 2 Müller-Jakic B, Breu W, Pröbstle A, Redl K, Greger H, Bauer R. In vitro inhibition of cyclooxygenase and lipoxygenase by alkamides from Echinacea and Achillea species. Planta Medica. 1994; 60 37-40
- 3 Facino R M, Carini M, Aldini G, Saibene L, Pietta P, Mauri P. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: A potential use of Echinacea extracts in the prevention of skin photodamage. Planta Medica. 1995; 61 510-4
- 4 Beuscher N, Bodinet C, Willigmann I, Egert D. Immunmodulierende Eigenschaften von Wurzelextrakten verschiedener Echinacea-Arten. Zeitschrift für Phytotherapie. 1995; 16 157-69
- 5 Dietz B, Heilmann J, Bauer R. Bioavailability of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides. Planta Medica. 2001; 67 863-4
- 6 O’Flaherty L, Stapleton P P, Redmond H P, Bouchier-Hayes D. Dexamethasone and lipopolysaccharide regulation of taurine transport in Caco-2 cells. Journal of Surgical Research. 1997; 69 331-6
- 7 Ogle C K, Guo X, Hasselgren P O, Ogle J D, Alexander J W. The gut as a source of inflammatory cytokines after stimulation with endotoxin. European Journal of Surgery. 1997; 163 45-51
- 8 Schuerer-Maly C C, Eckmann L, Kagnoff M F, Falco M T, Maly F E. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology. 1994; 81 85-91
- 9 Hidalgo I J, Borchardt R T. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochimica et Biophysica Acta. 1990; 1035 97-103
- 10 Bauer R, Remiger P, Wagner H. Alkamides from the roots of Echinacea purpurea . Phytochemistry. 1988; 27 2339-42
-
11 Artursson P, Karlsson J, Ocklind G, Schipper N. Studying transport processes in absorptive epithelia. In: Shaw AJ
Epithelial cell culture . IRL Press Oxford 1996: 111-33 - 12 Heilmann J, Wasescha M R, Schmidt T J. The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells. Bioorganic and Medicinal Chemistry. 2001; 9 2189-94
1 This article is dedicated in deep gratitude to Prof. Dr. Otto Sticher (ETH Zurich, Institute of Pharmaceutical Sciences) on the occasion of his 65th birthday.
Dr. Jörg Heilmann
ETH Zurich
Institute of Pharmaceutical Sciences
Winterthurerstr. 190
8057 Zürich
Switzerland
eMail: heilmann@pharma.ethz.ch
Telefon: +41-1-6356049